ArticlePain and therapy2024

Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study.

David True et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.